BenevolentAI: From Machine Learning Startup towards New Drug Producer
BenevolentAI is using machine learning to gather insights from the body of pharmaceutical literature in order to produce new potential drugs, but can it keep top talent?
The HBS Digital Initiative reshapes digital to create a world where technology advances and serves humanity. The DI manages this forum to highlight perspectives from the HBS student community.
Want to learn more about technology and organizations? digital.hbs.edu
Close and dismiss.
Expand.